These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16296572)

  • 41. Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: the NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) study.
    Vitale C; Marazzi G; Iellamo F; Spoletini I; Dall'Armi V; Fini M; Volterrani M
    Int J Cardiol; 2012 Mar; 155(2):279-84. PubMed ID: 22078979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I-II hypertension.
    Germino FW; Lin Y; Pejović V; Bowen L
    Ther Adv Cardiovasc Dis; 2012 Oct; 6(5):185-99. PubMed ID: 23008339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison between nebivolol and ramipril in patients with hypertension and left ventricular hypertrophy: a randomized open blinded end-point (PROBE) trial.
    Cağlar N; Dincer I
    Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1359-68. PubMed ID: 22288296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nebivolol in the management of essential hypertension: a review.
    McNeely W; Goa KL
    Drugs; 1999 Apr; 57(4):633-51. PubMed ID: 10235696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood pressure effects of combined β-blocker and angiotensin-converting enzyme inhibitor therapy compared with the individual agents: a placebo-controlled study with nebivolol and lisinopril.
    Weber MA; Basile J; Stapff M; Khan B; Zhou D
    J Clin Hypertens (Greenwich); 2012 Sep; 14(9):588-92. PubMed ID: 22947356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol.
    Nodari S; Metra M; Dei Cas L
    Eur J Heart Fail; 2003 Oct; 5(5):621-7. PubMed ID: 14607201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients.
    Tarighi B; Kurum T; Demir M; Azcan SN
    Can J Cardiol; 2007 Jun; 23(8):651-5. PubMed ID: 17593991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol.
    Yilmaz MB; Erdem A; Yalta K; Turgut OO; Yilmaz A; Tandogan I
    Adv Ther; 2008 Sep; 25(9):871-83. PubMed ID: 18758699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. the QoLaN study.
    Hermans MP; De Coster O; Seidel L; Albert A; Van de Borne P
    Blood Press Suppl; 2009 Oct; 1():5-14. PubMed ID: 20050100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The antihypertensive and cardiac hemodynamic effects of nebivolol.
    DeCrée J; Van Rooy P; Geukens H; Haeverans K; Verhaegen H
    Angiology; 1992 May; 43(5):369-77. PubMed ID: 1348916
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Verapamil and nebivolol improve carotid artery distensibility in hypertensive patients.
    van Merode T; van Bortel LM; Smeets FA; Mooij JM; Bohm RO; Rahn KH; Reneman RS
    J Hypertens Suppl; 1989 Dec; 7(6):S262-3. PubMed ID: 2576665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients.
    Poirier L; Cléroux J; Nadeau A; Lacourcière Y
    J Hypertens; 2001 Aug; 19(8):1429-35. PubMed ID: 11518851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nebivolol withdrawal results in blood pressure returning toward pretreatment levels, but without rebound symptoms: phase IV randomized trial.
    Lewin A; Lasseter KC; Dong F; Whalen JC
    J Am Soc Hypertens; 2012; 6(3):228-36. PubMed ID: 22421631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study.
    Neutel JM; Giles TD; Punzi H; Weiss RJ; Li H; Finck A
    J Am Soc Hypertens; 2014 Dec; 8(12):915-20. PubMed ID: 25492835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness.
    Kampus P; Serg M; Kals J; Zagura M; Muda P; Karu K; Zilmer M; Eha J
    Hypertension; 2011 Jun; 57(6):1122-8. PubMed ID: 21536983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study.
    Vaz-de-Melo RO; Giollo-Júnior LT; Martinelli DD; Moreno-Júnior H; Mota-Gomes MA; Cipullo JP; Yugar-Toledo JC; Vilela-Martin JF
    Sao Paulo Med J; 2014; 132(5):290-6. PubMed ID: 25054966
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nebivolol/hydrochlorothiazide (HCTZ) combination in patients with essential hypertension: a pooled analysis from five non-interventional studies with a focus on diabetic and elderly patients.
    Malacco E
    Eur Rev Med Pharmacol Sci; 2010 May; 14(5):427-34. PubMed ID: 20556921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease: a SPECT study.
    Saura H; Ogasawara K; Suzuki T; Kuroda H; Yamashita T; Kobayashi M; Terasaki K; Ogawa A
    Cerebrovasc Dis; 2012; 33(4):354-61. PubMed ID: 22433127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.